Resultats de la cerca - Pearse, Roger
- Mostrar 1 - 17 resultats de 17
-
1
BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma per Rossi, Adriana, Mark, Tomer, Jayabalan, David, Christos, Paul, Zafar, Faiza, Pekle, Karen, Pearse, Roger, Chen-Kiang, Selina, Coleman, Morton, Niesvizky, Ruben
Publicat 2013Text -
2
Age matters: Young T lymphocytes offer better protection from myeloma proliferation per Glick, Alexander F, Song, Yan S, Hwang, Brian, Lillvis, John, Zanzonico, Pat, Fuchs, Camil, Pearse, Roger N, Szabo, Paul, Weksler, Marc E
Publicat 2013Text -
3
A Phase 1 Study of Bendamustine and Melphalan Conditioning for Autologous Stem Cell Transplantation in Multiple Myeloma per Mark, Tomer M., Reid, Whitney, Niesvizky, Ruben, Gergis, Usama, Pearse, Roger, Mayer, Sebastian, Greenberg, June, Coleman, Morton, Van Besien, Koen, Shore, Tsiporah
Publicat 2013Text -
4
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression per Pearse, Roger N., Sordillo, Emilia M., Yaccoby, Shmuel, Wong, Brian R., Liau, Deng F., Colman, Neville, Michaeli, Joseph, Epstein, Joshua, Choi, Yongwon
Publicat 2001Text -
5
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma per Mark, Tomer M., Forsberg, Peter A., Rossi, Adriana C., Pearse, Roger N., Pekle, Karen A., Perry, Arthur, Boyer, Angelique, Tegnestam, Linda, Jayabalan, David, Coleman, Morton, Niesvizky, Ruben
Publicat 2019Text -
6
Cord Blood Chimerism And Relapse After Haplo-Cord Transplantation per van Besien, Koen, Koshy, Nebu, Gergis, Usama, Mayer, Sebastian, Cushing, Melissa, Rennert, Hannah, Slotky, Ronit, Mark, Tomer, Pearse, Roger, Rossi, Adriana, Phillips, Adrienne, Vasovic, Liljana, Ferrante, Rosanna, Hsu, Michael, Shore, Tsiporah
Publicat 2016Text -
7
Haplo-cord transplant: HLA-matching Determines Graft Dominance per van Besien, Koen, Koshy, Nebu, Gergis, Usama, Mayer, Sebastian, Cushing, Melissa, Rennert, Hannah, Slotky, Ronit, Mark, Tomer, Pearse, Roger, Rossi, Adriana, Phillips, Adrienne, Vasovic, Liljana, Ferrante, Rosanna, Hsu, Michael, Shore, Tsiporah
Publicat 2016Text -
8
Granulocyte Colony-Stimulating Factor Use After Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices per Singh, Amrita D., Parmar, Sapna, Patel, Khilna, Shah, Shreya, Shore, Tsiporah, Gergis, Usama, Mayer, Sebastian, Phillips, Adrienne, Hsu, Jing-Mei, Niesvizky, Ruben, Mark, Tomer M., Pearse, Roger, Rossi, Adriana, van Besien, Koen
Publicat 2017Text -
9
Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma per Mark, Tomer, Stern, Jessica, Furst, Jessica R., Jayabalan, David, Zafar, Faiza, LaRow, April, Pearse, Roger N., Harpel, John, Shore, Tsiporah, Schuster, Michael W., Leonard, John P., Christos, Paul J., Coleman, Morton, Niesvizky, Ruben
Publicat 2008Text -
10
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin per Nardiello, Tricia, Jungbluth, Achim A., Mei, Anna, DiLiberto, Maurizio, Huang, Xiangao, Dabrowski, Ania, Andrade, Valéria C. C., Wasserstrum, Rebecca, Ely, Scott, Niesvizky, Ruben, Pearse, Roger, Coleman, Morton, Jayabalan, David S., Bhardwaj, Nina, Old, Lloyd J., Chen-Kiang, Selina, Cho, Hearn Jay
Publicat 2011Text -
11
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma per Mark, Tomer, Jayabalan, David, Coleman, Morton, Pearse, Roger N., Wang, Y. Lynn, Lent, Richard, Christos, Paul J., Lee, Joong W., Agrawal, Yashpal P., Matthew, Susan, Ely, Scott, Mazumdar, Madhu, Cesarman, Ethel, Leonard, John P., Furman, Richard R., Chen-Kiang, Selina, Niesvizky, Ruben
Publicat 2008Text -
12
Overcoming the response plateau in multiple myeloma: A novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization per Niesvizky, Ruben, Mark, Tomer M., Ward, Maureen, Jayabalan, David S., Pearse, Roger N., Manco, Megan, Stern, Jessica, Christos, Paul J., Mathews, Lena, Shore, Tsiporah B., Zafar, Faiza, Pekle, Karen, Xiang, Zhaoying, Ely, Scott, Skerret, Donna, Chen-Kiang, Selina, Coleman, Morton, Lane, Maureen E.
Publicat 2013Text -
13
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma per Gay, Francesca, Rajkumar, S. Vincent, Coleman, Morton, Kumar, Shaji, Mark, Tomer, Dispenzieri, Angela, Pearse, Roger, Gertz, Morie A., Leonard, John, Lacy, Martha Q., Cheng-Kiang, Selina, Roy, Vivek, Jayabalan, David S., Lust, John A., Witzig, Thomas E., Fonseca, Rafael, Kyle, Robert A., Greipp, Philip R., Stewart, A. Keith, Niesvizky, Ruben
Publicat 2010Text -
14
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference per Lipton, Allan, Berenson, James R., Body, Jean-Jacques, Boyce, Brendan F., Bruland, Oyvind S., Carducci, Michael A., Cleeland, Charles S., Clohisy, Denis R., Coleman, Robert E., Cook, Richard J., Guise, Theresa A., Pearse, Roger N., Powles, Trevor J., Rogers, Michael J., Roodman, G. David, Smith, Matthew R., Suva, Larry J., Vessella, Robert L., Weilbaecher, Katherine N., King, Laura
Publicat 2006Text -
15
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers per Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara, Patel, Dhwani, Smith, Eric, Korde, Neha, Lu, Sydney, Mailankody, Sham, Shah, Urvi, Lesokhin, Alexander, Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkacs, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetsky, David, Braunstein, Marc, Gordillo, Christian, Davies, Faith, Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth, Landgren, Ola
Publicat 2020Text -
16
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers per Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara A., Patel, Dhwani, Smith, Eric L., Korde, Neha, Lu, Sydney X., Mailankody, Sham, Shah, Urvi A., Lesokhin, Alexander M., Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkach, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger N., Madduri, Deepu, Chari, Ajai, Kaminetzky, David, Braunstein, Marc J., Gordillo, Christian, Reshef, Ran, Taur, Ying, Davies, Faith E., Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth J., Landgren, Ola
Publicat 2020Text -
17
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers per Hultcrantz, Malin, Richter, Joshua, Rosenbaum, Cara A., Patel, Dhwani, Smith, Eric L., Korde, Neha, Lu, Sydney X., Mailankody, Sham, Shah, Urvi A., Lesokhin, Alexander M., Hassoun, Hani, Tan, Carlyn, Maura, Francesco, Derkach, Andriy, Diamond, Benjamin, Rossi, Adriana, Pearse, Roger, Madduri, Deepu, Chari, Ajai, Kaminetzky, David, Braunstein, Marc J., Gordillo, Christian, Reshef, Ran, Taur, Ying, Davies, Faith E., Jagannath, Sundar, Niesvizky, Ruben, Lentzsch, Suzanne, Morgan, Gareth J., Landgren, Ola
Publicat 2020Text